3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
2
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
49
Prostatic Neoplasms
38
Carcinoma, Non-Small-Cell Lung
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Neoplasms
23
Multiple Myeloma
22
Lymphoma
21
Leukemia, Myeloid, Acute
17
Colorectal Neoplasms
17
Melanoma
15
Lung Neoplasms
13
Hodgkin Disease
11
Brain Neoplasms
11
Medulloblastoma
10
Lymphoma, Non-Hodgkin
10
Glioblastoma
10
Squamous Cell Carcinoma of Head and Neck
9
Pancreatic Neoplasms
9
Neoplasm Metastasis
9
Leukemia, Biphenotypic, Acute
9
Leukemia
9
Head and Neck Neoplasms
9
HIV Infections
9
Neuroblastoma
8
Hematologic Neoplasms
8
Ependymoma
8
Glioma
7
Carcinoma, Renal Cell
7
Astrocytoma
7
Wilms Tumor
6
Interventions
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Breast Cancer Recurrent
×
1 year
×
Clear all
NCT03820830
2026-04-09
POLAR
ETOP IBCSG Partners Foundation
Phase 3
Active not recruiting
405 enrolled